{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T18:36:28Z","timestamp":1782585388084,"version":"3.54.5"},"reference-count":171,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T00:00:00Z","timestamp":1539648000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003339","name":"Consejo Superior de Investigaciones Cient\u00edficas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.02252","type":"journal-article","created":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T05:19:25Z","timestamp":1539667165000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":114,"title":["Phage Lysins for Fighting Bacterial Respiratory Infections: A New Generation of Antimicrobials"],"prefix":"10.3389","volume":"9","author":[{"given":"Roberto","family":"V\u00e1zquez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernesto","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,10,16]]},"reference":[{"key":"B1","volume-title":"The Top 10 Causes of Death","author":"World","year":"2017"},{"key":"B2","volume-title":"Pneumonia","author":"World","year":"2016"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e01318","DOI":"10.1128\/JCM.01318-17","article-title":"Community-acquired pneumonia in children: the challenges of microbiological diagnosis","volume":"56","author":"Rodrigues","year":"2018","journal-title":"J Clin Microbiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.rmed.2018.02.007","article-title":"Burden of pneumococcal community-acquired pneumonia in adults across Europe: a literature review","volume":"137","author":"Torres","year":"2018","journal-title":"Respir Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1080\/14656566.2018.1438408","article-title":"Novel pharmacotherapy for the treatment of hospital-acquired and ventilator-associated pneumonia caused by resistant Gram-negative bacteria","volume":"19","author":"Kidd","year":"2018","journal-title":"Expert Opin Pharmacother."},{"key":"B6","unstructured":"O'NeillJ\n          Review on Antimicrobial Resistance. Antimicrobial Resistance: Tackling a Crisis for the Health and Wealth of Nations2014"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e1002184","DOI":"10.1371\/journal.pmed.1002184","article-title":"Will 10 million people die a year due to antimicrobial resistance by 2050?","volume":"13","author":"de","year":"2016","journal-title":"PLoS Med"},{"key":"B8","unstructured":"WorldBank\n          Drug-Resistant Infections: A Threat to our Economic Future2017"},{"key":"B9","author":"World","year":"2018","journal-title":"Antimicrobial Resistance"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1093\/cid\/cix226","article-title":"'Fight antibiotic resistance\u2014It's in your hands': call from the World Health Organization for 5th May 2017","volume":"64","author":"Pires","year":"2017","journal-title":"Clin Infect Dis."},{"key":"B11","doi-asserted-by":"publisher","first-page":"fnx230","DOI":"10.1093\/femsle\/fnx230","article-title":"Antibiotic stewardship: a European perspective","volume":"364","author":"Pulcini","year":"2017","journal-title":"FEMS Microbiol Lett"},{"key":"B12","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/S0140-6736(15)00473-0","article-title":"Understanding the mechanisms and drivers of antimicrobial resistance","volume":"387","author":"Holmes","year":"2016","journal-title":"Lancet"},{"key":"B13","doi-asserted-by":"publisher","first-page":"E99","DOI":"10.1016\/S1473-3099(17)30485-1","article-title":"Surveillance for control of antimicrobial resistance","volume":"18","author":"Tacconelli","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"B14","author":"World","year":"2017","journal-title":"Global Priority List of Antibiotic-Resistant Bacteria to Guide Research, Discovery, and Development of New Antibiotics"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1086\/533452","article-title":"Federal funding for the study of antimicrobial resistance in nosocomial pathogens: No ESKAPE","volume":"197","author":"Rice","year":"2008","journal-title":"J Infect Dis"},{"key":"B16","author":"World","year":"2018","journal-title":"Global Tuberculosis Report 2018"},{"key":"B17","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3390\/ph11020034","article-title":"Enhancing whole phage therapy and their derived antimicrobial enzymes through complex formulation","volume":"11","author":"Cooper","year":"2018","journal-title":"Pharmaceuticals"},{"key":"B18","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.biotechadv.2017.12.009","article-title":"Synthetic biology of modular endolysins","volume":"36","author":"Gerstmans","year":"2018","journal-title":"Biotechnol Adv"},{"key":"B19","doi-asserted-by":"publisher","first-page":"275","DOI":"10.2217\/fmb-2017-0235","article-title":"Phage-derived lysins as therapeutic agents against multidrug-resistant Enterococcus faecalis","volume":"13","author":"Gu","year":"2018","journal-title":"Future Microbiol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e01923","DOI":"10.1128\/mBio.01923-17","article-title":"Are phage lytic proteins the secret weapon to kill Staphylococcus aureus?","volume":"9","author":"Guti\u00e9rrez","year":"2018","journal-title":"mBio"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e00071","DOI":"10.1128\/CMR.00071-17","article-title":"Recombinant endolysins as potential therapeutics against antibiotic-resistant Staphylococcus aureus: current status of research and novel delivery strategies","volume":"31","author":"Haddad","year":"2018","journal-title":"Clin Microbiol Rev."},{"key":"B22","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3390\/antibiotics7010017","article-title":"Potential for bacteriophage endolysins to supplement or replace antibiotics in food production and clinical care","volume":"7","author":"Love","year":"2018","journal-title":"Antibiotics"},{"key":"B23","doi-asserted-by":"publisher","first-page":"292","DOI":"10.3390\/v10060292","article-title":"Phage-derived peptidoglycan degrading enzymes: challenges and future prospects for in vivo therapy","volume":"10","author":"Oliveira","year":"2018","journal-title":"Viruses"},{"key":"B24","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3390\/antibiotics7020029","article-title":"Engineering of phage-derived lytic enzymes: improving their potential as antimicrobials","volume":"7","author":"S\u00e3o-Jos\u00e9","year":"2018","journal-title":"Antibiotics"},{"key":"B25","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.drudis.2018.01.026","article-title":"Phage-derived lysins as potential agents for eradicating biofilms and persisters","volume":"23","author":"Sharma","year":"2018","journal-title":"Drug Discov Today"},{"key":"B26","doi-asserted-by":"publisher","first-page":"310","DOI":"10.3390\/v10060310","article-title":"Development of phage lysins as novel therapeutics: a historical perspective","volume":"10","author":"Fischetti","year":"2018","journal-title":"Viruses"},{"key":"B27","doi-asserted-by":"publisher","first-page":"4107","DOI":"10.1073\/pnas.061038398","article-title":"Prevention and elimination of upper respiratory colonization of mice by group A streptococci by using a bacteriophage lytic enzyme","volume":"98","author":"Nelson","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"B28","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1089\/mdr.1997.3.199","article-title":"The pneumococcal cell wall degrading enzymes: a modular design to create new lysins?","volume":"3","author":"L\u00f3pez","year":"1997","journal-title":"Microb Drug Resist."},{"key":"B29","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1046\/j.1365-2958.2002.02889.x","article-title":"C-terminal domains of Listeria monocytogenes bacteriophage murein hydrolases determine specific recognition and high-affinity binding to bacterial cell wall carbohydrates","volume":"44","author":"Loessner","year":"2002","journal-title":"Mol Microbiol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1038\/nature01026","article-title":"A bacteriolytic agent that detects and kills Bacillus anthracis","volume":"418","author":"Schuch","year":"2002","journal-title":"Nature"},{"key":"B31","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.bbrc.2009.03.161","article-title":"The high-affinity peptidoglycan binding domain of Pseudomonas phage endolysin KZ144","volume":"383","author":"Briers","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"B32","doi-asserted-by":"publisher","first-page":"10164","DOI":"10.1038\/s41598-017-10755-7","article-title":"Endolysin LysEF-P10 shows potential as an alternative treatment strategy for multidrug-resistant Enterococcus faecalis infections","volume":"7","author":"Cheng","year":"2017","journal-title":"Sci Rep."},{"key":"B33","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1128\/AAC.02526-12","article-title":"Novel bacteriophage lysin with broad lytic activity protects against mixed infection by Streptococcus pyogenes and methicillin-resistant Staphylococcus aureus","volume":"57","author":"Gilmer","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"B34","doi-asserted-by":"publisher","first-page":"3774","DOI":"10.1128\/AAC.02668-14","article-title":"Art-175 is a highly efficient antibacterial against multidrug-resistant strains and persisters of Pseudomonas aeruginosa","volume":"58","author":"Briers","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"B35","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1128\/AAC.00786-06","article-title":"Lysostaphin-resistant variants of Staphylococcus aureus demonstrate reduced fitness in vitro and in vivo","volume":"51","author":"Kusuma","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1128\/AAC.04641-14","article-title":"Novel phage lysin capable of killing the multidrug-resistant gram-negative bacterium Acinetobacter baumannii in a mouse bacteremia model","volume":"59","author":"Lood","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"B37","doi-asserted-by":"publisher","first-page":"e0192507","DOI":"10.1371\/journal.pone.0192507","article-title":"In vitro characterization of PlyE146, a novel phage lysin that targets Gram-negative bacteria","volume":"13","author":"Larpin","year":"2018","journal-title":"PLoS ONE"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.3389\/fmicb.2016.01156","article-title":"PL3 amidase, a tailor-made lysin constructed by domain shuffling with potent killing activity against pneumococci and related species","volume":"7","author":"Bl\u00e1zquez","year":"2016","journal-title":"Front Microbiol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"16506","DOI":"10.1038\/s41598-017-16736-0","article-title":"Csl2, a novel chimeric bacteriophage lysin to fight infections caused by Streptococcus suis, an emerging zoonotic pathogen","volume":"7","author":"V\u00e1zquez","year":"2017","journal-title":"Sci Rep"},{"key":"B40","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1126\/science.1066869","article-title":"Rapid killing of Streptococcus pneumoniae with a bacteriophage cell wall hydrolase","volume":"294","author":"Loeffler","year":"2001","journal-title":"Science"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1093\/jac\/dkv038","article-title":"A novel chimeric phage lysin with high in vitro and in vivo bactericidal activity against Streptococcus pneumoniae","volume":"70","author":"D\u00edez-Mart\u00ednez","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.3389\/fmicb.2015.01471","article-title":"Antibacterial activity of a novel peptide-modified lysin against Acinetobacter baumannii and Pseudomonas aeruginosa","volume":"6","author":"Yang","year":"2015","journal-title":"Frontiers Microbiol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1128\/AAC.47.1.375-377.2003","article-title":"Synergistic lethal effect of a combination of phage lytic enzymes with different activities on penicillin-sensitive and -resistant Streptococcus pneumoniae strains","volume":"47","author":"Loeffler","year":"2003","journal-title":"Antimicrob Agents Chemother."},{"key":"B44","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1093\/jac\/dkg485","article-title":"Phage lytic enzymes as therapy of antibiotic-resistant Streptococcus pneumoniae infection in a murine sepsis model","volume":"52","author":"Jado","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"B45","doi-asserted-by":"publisher","first-page":"4144","DOI":"10.1128\/AAC.00492-11","article-title":"In vitro destruction of Streptococcus pneumoniae biofilms with bacterial and phage peptidoglycan hydrolases","volume":"55","author":"Domenech","year":"2011","journal-title":"Antimicrob Agents Chemother."},{"key":"B46","doi-asserted-by":"publisher","first-page":"6199","DOI":"10.1128\/IAI.71.11.6199-6204.2003","article-title":"Phage lytic enzyme Cpl-1 as a novel antimicrobial for pneumococcal bacteremia","volume":"71","author":"Loeffler","year":"2003","journal-title":"Infect Immun"},{"key":"B47","doi-asserted-by":"publisher","first-page":"e28","DOI":"10.1371\/journal.ppat.0030028","article-title":"Novel strategy to prevent otitis media caused by colonizing Streptococcus pneumoniae","volume":"3","author":"McCullers","year":"2007","journal-title":"PLoS Pathog."},{"key":"B48","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1093\/jac\/dkt131","article-title":"Delivery of the endolysin Cpl-1 by inhalation rescues mice with fatal pneumococcal pneumonia","volume":"68","author":"Doehn","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"B49","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.ijantimicag.2013.06.020","article-title":"Bactericidal synergism between daptomycin and the phage lysin Cpl-1 in a mouse model of pneumococcal bacteraemia","volume":"42","author":"Vouillamoz","year":"2013","journal-title":"Int J Antimicrob Agents"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1128\/AAC.49.3.1225-1228.2005","article-title":"Synergistic killing of Streptococcus pneumoniae with the bacteriophage lytic enzyme Cpl-1 and penicillin or gentamicin depends on the level of penicillin resistance","volume":"49","author":"Djurkovic","year":"2005","journal-title":"Antimicrob Agents Chemother."},{"key":"B51","doi-asserted-by":"publisher","first-page":"e02212","DOI":"10.1128\/AAC.02212-17","article-title":"Chemotherapy with phage lysins reduces pneumococcal colonization of the respiratory tract","volume":"62","author":"Corsini","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"B52","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1097\/CCM.0b013e31819586a6","article-title":"Systemic use of the endolysin Cpl-1 rescues mice with fatal pneumococcal pneumonia","volume":"37","author":"Witzenrath","year":"2009","journal-title":"Crit Care Med."},{"key":"B53","doi-asserted-by":"publisher","first-page":"5355","DOI":"10.1128\/AAC.01372-13","article-title":"Improving the lethal effect of Cpl-7, a pneumococcal phage lysozyme with broad bactericidal activity, by inverting the net charge of its cell wall-binding module","volume":"57","author":"D\u00edez-Mart\u00ednez","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"B54","doi-asserted-by":"crossref","DOI":"10.2217\/fmb-2018-0077","article-title":"Bactericidal synergism between antibiotics and phage endolysin Cpl-711 to kill multidrug-resistant pneumococcus","author":"Letrado","year":"2018","journal-title":"Future Microbiol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"10765","DOI":"10.1073\/pnas.0604521103","article-title":"PlyC: a multimeric bacteriophage lysin","volume":"103","author":"Nelson","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"B56","doi-asserted-by":"publisher","first-page":"e13152","DOI":"10.7554\/eLife.13152","article-title":"A bacteriophage endolysin that eliminates intracellular streptococci","volume":"5","author":"Shen","year":"2016","journal-title":"eLife"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1093\/jac\/dkt104","article-title":"Rapid degradation of Streptococcus pyogenes biofilms by PlyC, a bacteriophage-encoded endolysin","volume":"68","author":"Shen","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"B58","doi-asserted-by":"publisher","first-page":"3073","DOI":"10.1128\/AAC.00115-14","article-title":"A highly active and negatively charged Streptococcus pyogenes lysin with a rare D-alanyl-L-alanine endopeptidase activity protects mice against streptococcal bacteremia","volume":"58","author":"Lood","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"B59","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1128\/AAC.49.1.111-117.2005","article-title":"Removal of group B streptococci colonizing the vagina and oropharynx of mice with a bacteriophage lytic enzyme","volume":"49","author":"Cheng","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1007\/s00253-006-0771-1","article-title":"Mutagenesis of a bacteriophage lytic enzyme PlyGBS significantly increases its antibacterial activity against group B streptococci","volume":"74","author":"Cheng","year":"2007","journal-title":"Appl Microbiol Biotechnol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1093\/jac\/dku552","article-title":"Evolutionarily distinct bacteriophage endolysins featuring conserved peptidoglycan cleavage sites protect mice from MRSA infection","volume":"70","author":"Schmelcher","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1128\/AAC.47.5.1589-1597.2003","article-title":"Lysostaphin cream eradicates Staphylococcus aureus nasal colonization in a cotton rat model","volume":"47","author":"Kokai-Kun","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1023\/B:PHAM.0000045227.16829.37","article-title":"Extended nasal residence time of lysostaphin and an anti-staphylococcal monoclonal antibody by delivery in semisolid or polymeric carriers","volume":"21","author":"Walsh","year":"2004","journal-title":"Pharm Res"},{"key":"B64","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jconrel.2016.11.030","article-title":"Thermally triggered release of the bacteriophage endolysin CHAPK and the bacteriocin lysostaphin for the control of methicillin resistant Staphylococcus aureus (MRSA)","volume":"245","author":"Hathaway","year":"2017","journal-title":"J Control Release"},{"key":"B65","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/0732-8893(93)90034-5","article-title":"In vitro activity of recombinant lysostaphin-antibiotic combinations toward methicillin-resistant Staphylococcus aureus","volume":"17","author":"Polak","year":"1993","journal-title":"Diagn Microbiol Infect Dis."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1128\/AAC.45.5.1431-1437.2001","article-title":"Mechanism and suppression of lysostaphin resistance in oxacillin-resistant Staphylococcus aureus","volume":"45","author":"Climo","year":"2001","journal-title":"Antimicrob Agents Chemother."},{"key":"B67","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1128\/AAC.46.6.2017-2020.2002","article-title":"Combinations of lysostaphin with \u03b2-lactams are synergistic against oxacillin-resistant Staphylococcus epidermidis","volume":"46","author":"Kiri","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"B68","doi-asserted-by":"publisher","first-page":"3407","DOI":"10.1128\/AAC.47.11.3407-3414.2003","article-title":"Lysostaphin disrupts Staphylococcus aureus and Staphylococcus epidermidis biofilms on artificial surfaces","volume":"47","author":"Wu","year":"2003","journal-title":"Antimicrob Agents Chemother."},{"key":"B69","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1128\/AAC.47.2.554-558.2003","article-title":"Improved pharmacokinetics and reduced antibody reactivity of lysostaphin conjugated to polyethylene glycol","volume":"47","author":"Walsh","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1093\/jac\/dkm347","article-title":"Lysostaphin as a treatment for systemic Staphylococcus aureus infection in a mouse model","volume":"60","author":"Kokai-Kun","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"B71","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/j.1574-6968.2008.01308.x","article-title":"The phage K lytic enzyme LysK and lysostaphin act synergistically to kill MRSA","volume":"287","author":"Becker","year":"2008","journal-title":"FEMS Microbiol Lett."},{"key":"B72","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.ijantimicag.2011.02.009","article-title":"Lysostaphin and clarithromycin: a promising combination for the eradication of Staphylococcus aureus biofilms","volume":"37","author":"Aguinaga","year":"2011","journal-title":"Int J Antimicrob Agents"},{"key":"B73","doi-asserted-by":"publisher","first-page":"7161","DOI":"10.1128\/JB.187.20.7161-7164.2005","article-title":"The recombinant phage lysin LysK has a broad spectrum of lytic activity against clinically relevant staphylococci, including methicillin-resistant Staphylococcus aureus","volume":"187","author":"O'Flaherty","year":"2005","journal-title":"J Bacteriol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1016\/j.biochi.2013.04.013","article-title":"Physicochemical characterization of the staphylolytic LysK enzyme in complexes with polycationic polymers as a potent antimicrobial","volume":"95","author":"Filatova","year":"2013","journal-title":"Biochimie"},{"key":"B75","doi-asserted-by":"publisher","first-page":"404","DOI":"10.4161\/bbug.1.6.13422","article-title":"The truncated phage lysin CHAPk eliminates Staphylococcus aureus in the nares of mice","volume":"1","author":"Fenton","year":"2010","journal-title":"Bioeng Bugs"},{"key":"B76","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1128\/AEM.01831-08","article-title":"Phage lysin LysK can be truncated to its CHAP domain and retain lytic activity against live antibiotic-resistant staphylococci","volume":"75","author":"Horgan","year":"2009","journal-title":"Appl Environ Microbiol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1111\/j.1365-2672.2011.05119.x","article-title":"Characterization of the staphylococcal bacteriophage lysin CHAPK","volume":"111","author":"Fenton","year":"2011","journal-title":"J Appl Microbiol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"625341","DOI":"10.1155\/2013\/625341","article-title":"Bacteriophage-derived peptidase CHAPK eliminates and prevents staphylococcal biofilms","volume":"2013","author":"Fenton","year":"2013","journal-title":"Int J Microbiol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1128\/AAC.01625-09","article-title":"Synergism between a novel chimeric lysin and oxacillin protects against infection by methicillin-resistant Staphylococcus aureus","volume":"54","author":"Daniel","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"B80","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1128\/AAC.02232-13","article-title":"Preclinical safety evaluation of intravenously administered SAL200 containing the recombinant phage endolysin SAL-1 as a pharmaceutical ingredient","volume":"58","author":"Jun","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1111\/1440-1681.12613","article-title":"Pharmacokinetics of the phage endolysin-based candidate drug SAL200 in monkeys and its appropriate intravenous dosing period","volume":"43","author":"Jun","year":"2016","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"e02629","DOI":"10.1128\/AAC.02629-16","article-title":"Pharmacokinetics and tolerance of the phage endolysin-based candidate drug SAL200 after a single intravenous administration among healthy volunteers","volume":"61","author":"Jun","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"B83","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1128\/AAC.01097-10","article-title":"Comparison of the antibacterial properties of phage endolysins SAL-1 and LysK","volume":"55","author":"Jun","year":"2011","journal-title":"Antimicrob Agents Chemother."},{"key":"B84","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.ijantimicag.2012.10.011","article-title":"Antibacterial properties of a pre-formulated recombinant phage endolysin, SAL-1","volume":"41","author":"Jun","year":"2013","journal-title":"Int J Antimicrob Agents"},{"key":"B85","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/1471-2180-11-226","article-title":"A novel bacteriophage Tail-Associated Muralytic Enzyme (TAME) from phage K and its development into a potent antistaphylococcal protein","volume":"11","author":"Paul","year":"2011","journal-title":"BMC Microbiol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1471-2180-12-41","article-title":"Antistaphylococcal activity of bacteriophage derived chimeric protein P128","volume":"12","author":"Vipra","year":"2012","journal-title":"BMC Microbiol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/1756-0500-5-280","article-title":"Biochemical characterization and evaluation of cytotoxicity of antistaphylococcal chimeric protein P128","volume":"5","author":"George","year":"2012","journal-title":"BMC Res Notes"},{"key":"B88","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/alr.21680","article-title":"Fighting sinus-derived Staphylococcus aureus biofilms in vitro with a bacteriophage-derived muralytic enzyme","volume":"6","author":"Drilling","year":"2016","journal-title":"Int Forum Allergy Rhinol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"e00457","DOI":"10.1128\/AAC.00457-17","article-title":"Efficient killing of planktonic and biofilm-embedded coagulase-negative staphylococci by bactericidal protein P128","volume":"61","author":"Poonacha","year":"2017","journal-title":"Antimicrob Agents Chemother."},{"key":"B90","doi-asserted-by":"publisher","first-page":"7280","DOI":"10.1128\/AAC.01118-16","article-title":"Antibiofilm activity and synergistic inhibition of Staphylococcus aureus biofilms by bactericidal protein P128 in combination with antibiotics","volume":"60","author":"Nair","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"B91","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1099\/jmm.0.000697","article-title":"Restoration of sensitivity of a diverse set of drug-resistant Staphylococcus clinical strains by bactericidal protein P128","volume":"67","author":"Nair","year":"2018","journal-title":"J Med Microbiol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"e01358","DOI":"10.1128\/AAC.01358-17","article-title":"Efficacy of novel antistaphylococcal ectolysin P128 in a rat model of methicillin-resistant Staphylococcus aureus bacteremia","volume":"62","author":"Channabasappa","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"B93","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1128\/AEM.02581-15","article-title":"Combination therapy of LysGH15 and apigenin as a new strategy for treating pneumonia caused by Staphylococcus aureus","volume":"82","author":"Xia","year":"2016","journal-title":"Appl Environ Microbiol"},{"key":"B94","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1128\/JCM.01144-10","article-title":"LysGH15, a novel bacteriophage lysin, protects a murine bacteremia model efficiently against lethal methicillin-resistant Staphylococcus aureus infection","volume":"49","author":"Gu","year":"2011","journal-title":"J Clin Microbiol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"96","DOI":"10.4161\/bbug.2.2.14883","article-title":"LysGH15 reduces the inflammation caused by lethal methicillin-resistant Staphylococcus aureus infection in mice","volume":"2","author":"Gu","year":"2011","journal-title":"Bioeng Bugs"},{"key":"B96","doi-asserted-by":"publisher","first-page":"29344","DOI":"10.1038\/srep29344","article-title":"LysGH15 kills Staphylococcus aureus without being affected by the humoral immune response or inducing inflammation","volume":"6","author":"Zhang","year":"2016","journal-title":"Sci Rep."},{"key":"B97","doi-asserted-by":"publisher","first-page":"e00886","DOI":"10.1128\/AEM.00886-18","article-title":"Antibacterial effects of phage lysin LysGH15 on planktonic cells and biofilms of diverse staphylococci","volume":"84","author":"Zhang","year":"2018","journal-title":"Appl Environ Microbiol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1093\/infdis\/jit637","article-title":"Combination therapy with lysin CF-301 and antibiotic is superior to antibiotic alone for treating methicillin-resistant Staphylococcus aureus-induced murine bacteremia","volume":"209","author":"Schuch","year":"2014","journal-title":"J Infect Dis."},{"key":"B99","doi-asserted-by":"publisher","first-page":"e02666","DOI":"10.1128\/AAC.02666-16","article-title":"Bacteriophage lysin CF-301, a potent antistaphylococcal biofilm agent","volume":"61","author":"Schuch","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"B100","doi-asserted-by":"publisher","first-page":"40182","DOI":"10.1038\/srep40182","article-title":"A novel chimeric lysin with robust antibacterial activity against planktonic and biofilm methicillin-resistant Staphylococcus aureus","volume":"7","author":"Yang","year":"2017","journal-title":"Sci Rep."},{"key":"B101","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.enzmictec.2014.04.018","article-title":"Growth inhibition of Mycobacterium smegmatis by mycobacteriophage-derived enzymes","volume":"63","author":"Grover","year":"2014","journal-title":"Enzyme Microb Technol"},{"key":"B102","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1099\/mic.0.032821-0","article-title":"Mycobacteriophage Ms6 LysB specifically targets the outer membrane of Mycobacterium smegmatis","volume":"156","author":"Gil","year":"2010","journal-title":"Microbiology"},{"key":"B103","doi-asserted-by":"publisher","first-page":"19277","DOI":"10.3390\/molecules201019277","article-title":"Antimycobacterial activities of endolysins derived from a mycobacteriophage, BTCU-1","volume":"20","author":"Lai","year":"2015","journal-title":"Molecules"},{"key":"B104","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/S1389-1723(01)80275-9","article-title":"Antibacterial activity of Bacillus amyloliquefaciens phage endolysin without holin conjugation","volume":"91","author":"Morita","year":"2001","journal-title":"J Biosci Bioeng"},{"key":"B105","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/S0014-5793(01)02587-X","article-title":"Functional analysis of antibacterial activity of Bacillus amyloliquefaciens phage endolysin against Gram-negative bacteria","volume":"500","author":"Morita","year":"2001","journal-title":"FEBS Lett."},{"key":"B106","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s00253-003-1522-1","article-title":"Bacillus amyloliquefaciens phage endolysin can enhance permeability of Pseudomonas aeruginosa outer membrane and induce cell lysis","volume":"65","author":"Orito","year":"2004","journal-title":"Appl Microbiol Biotechnol."},{"key":"B107","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S1389-1723(99)80206-0","article-title":"Cloning and expression of a gene encoding the lytic functions of Bacillus amyloliquefaciens phage: evidence of an auxiliary lysis system","volume":"88","author":"Muyombwe","year":"1999","journal-title":"J Biosci Bioeng."},{"key":"B108","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1111\/j.1365-2958.2007.05870.x","article-title":"Muralytic activity and modular structure of the endolysins of Pseudomonas aeruginosa bacteriophages \u03c6KZ and EL","volume":"65","author":"Briers","year":"2007","journal-title":"Mol Microbiol."},{"key":"B109","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1111\/j.1365-2672.2010.04931.x","article-title":"Use of bacteriophage endolysin EL188 and outer membrane permeabilizers against Pseudomonas aeruginosa","volume":"110","author":"Briers","year":"2011","journal-title":"J Appl Microbiol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/j.1574-6968.2007.01051.x","article-title":"Analysis of outer membrane permeability of Pseudomonas aeruginosa and bactericidal activity of endolysins KZ144 and EL188 under high hydrostatic pressure","volume":"280","author":"Briers","year":"2008","journal-title":"FEMS Microbiol Lett."},{"key":"B111","doi-asserted-by":"publisher","first-page":"e36991","DOI":"10.1371\/journal.pone.0036991","article-title":"Characterization of modular bacteriophage endolysins from Myoviridae phages OBP, 201j2-1 and PVP-SE1","volume":"7","author":"Walmagh","year":"2012","journal-title":"PLoS ONE"},{"key":"B112","doi-asserted-by":"publisher","first-page":"3480","DOI":"10.1128\/AAC.00285-16","article-title":"Efficacy of artilysin Art-175 against resistant and persistent Acinetobacter baumannii","volume":"60","author":"Defraine","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"B113","doi-asserted-by":"publisher","first-page":"293","DOI":"10.3389\/fmicb.2017.00293","article-title":"A novel antimicrobial endolysin, LysPA26, against Pseudomonas aeruginosa","volume":"8","author":"Guo","year":"2017","journal-title":"Front Microbiol."},{"key":"B114","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s00253-011-3104-y","article-title":"Antibacterial activity of Acinetobacter baumannii phage \u03a6FB2 endolysin (LysAB2) against both Gram-positive and Gram-negative bacteria","volume":"90","author":"Lai","year":"2011","journal-title":"Appl Microbiol Biotechnol."},{"key":"B115","doi-asserted-by":"publisher","first-page":"11477","DOI":"10.1038\/s41598-017-11832-7","article-title":"Highly potent antimicrobial modified peptides derived from the Acinetobacter baumannii phage endolysin LysAB2","volume":"7","author":"Peng","year":"2017","journal-title":"Sci Rep."},{"key":"B116","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.3389\/fmicb.2016.01402","article-title":"Enhanced antibacterial activity of Acinetobacter baumannii bacteriophage \u00d8ABP-01 endolysin (LysABP-01) in combination with colistin","volume":"7","author":"Thummeepak","year":"2016","journal-title":"Front Microbiol"},{"key":"B117","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1186\/s12879-014-0681-2","article-title":"Antibacterial properties of Acinetobacter baumannii phage Abp1 endolysin (PlyAB1)","volume":"14","author":"Huang","year":"2014","journal-title":"BMC Infect Dis."},{"key":"B118","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.1128\/AAC.02972-15","article-title":"Novel engineered peptides of a phage lysin as effective antimicrobials against multidrug-resistant Acinetobacter baumannii","volume":"60","author":"Thandar","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"B119","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.ijantimicag.2013.04.022","article-title":"Identification and characterisation of the putative phage-related endolysins through full genome sequence analysis in Acinetobacter baumannii ATCC 17978","volume":"42","author":"Lai","year":"2013","journal-title":"Int J Antimicrob Agents"},{"key":"B120","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s11262-015-1195-8","article-title":"Genome sequencing and analysis of an Escherichia coli phage vB_EcoM-ep3 with a novel lysin, Lysep3","volume":"50","author":"Lv","year":"2015","journal-title":"Virus Genes"},{"key":"B121","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s12275-017-6431-6","article-title":"The antibacterial activity of E. coli bacteriophage lysin lysep3 is enhanced by fusing the Bacillus amyloliquefaciens bacteriophage endolysin binding domain D8 to the C-terminal region","volume":"55","author":"Wang","year":"2017","journal-title":"J Microbiol."},{"key":"B122","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1007\/s10482-017-0912-9","article-title":"The N-terminal and central domain of colicin A enables phage lysin to lyse Escherichia coli extracellularly","volume":"110","author":"Yan","year":"2017","journal-title":"Antonie van Leeuwenhoek"},{"key":"B123","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1111\/jam.13251","article-title":"In vitro study of the antibacterial effect of the bacteriophage T5 thermostable endolysin on Escherichia coli cells","volume":"121","author":"Shavrina","year":"2016","journal-title":"J Appl Microbiol."},{"key":"B124","doi-asserted-by":"publisher","first-page":"4369","DOI":"10.1007\/s00253-012-4294-7","article-title":"Characterization of five novel endolysins from Gram-negative infecting bacteriophages","volume":"97","author":"Walmagh","year":"2013","journal-title":"Appl Microbiol Biotechnol"},{"key":"B125","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s00253-016-7928-3","article-title":"Klebsiella phages representing a novel clade of viruses with an unknown DNA modification and biotechnologically interesting enzymes","volume":"101","author":"Maciejewska","year":"2017","journal-title":"Appl Microbiol Biotechnol."},{"key":"B126","doi-asserted-by":"publisher","first-page":"10543","DOI":"10.1007\/s00253-016-7858-0","article-title":"Characterization and genome sequencing of a Citrobacter freundii phage CfP1 harboring a lysin active against multidrug-resistant isolates","volume":"100","author":"Oliveira","year":"2016","journal-title":"Appl Microbiol Biotechnol."},{"key":"B127","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.3389\/fmicb.2015.01299","article-title":"Antibacterial activity of Stenotrophomonas maltophilia endolysin P28 against both Gram-positive and Gram-negative bacteria","volume":"6","author":"Dong","year":"2015","journal-title":"Front Microbiol."},{"key":"B128","doi-asserted-by":"publisher","first-page":"14501","DOI":"10.1038\/s41598-017-14797-9","article-title":"Modular endolysin of Burkholderia AP3 phage has the largest lysozyme-like catalytic subunit discovered to date and no catalytic aspartate residue","volume":"7","author":"Maciejewska","year":"2017","journal-title":"Sci Rep"},{"key":"B129","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.gene.2009.04.023","article-title":"Differentially conserved staphylococcal SH3b_5 cell wall binding domains confer increased staphylolytic and streptolytic activity to a streptococcal prophage endolysin domain","volume":"443","author":"Becker","year":"2009","journal-title":"Gene"},{"key":"B130","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.ddstr.2004.09.002","article-title":"Enzymes for anti-infective therapy: phage lysins","volume":"1","author":"L\u00f3pez","year":"2004","journal-title":"Drug Discov Today Ther Strateg"},{"key":"B131","doi-asserted-by":"publisher","first-page":"34391","DOI":"10.1074\/jbc.M111.244160","article-title":"Role of net charge on the catalytic domain and the influence of the cell-wall binding domain on the bactericidal activity, specificity, and host-range of phage lysins","volume":"286","author":"Low","year":"2011","journal-title":"J Biol Chem."},{"key":"B132","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.ijantimicag.2011.08.009","article-title":"A stable phage lysin (Cpl-1) dimer with increased antipneumococcal activity and decreased plasma clearance","volume":"38","author":"Resch","year":"2011","journal-title":"Int J Antimicrob Agents"},{"key":"B133","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/j.1574-6968.2008.01287.x","article-title":"LambdaSa2 prophage endolysin requires Cpl-7-binding domains and amidase-5 domain for antimicrobial lysis of streptococci","volume":"287","author":"Donovan","year":"2008","journal-title":"FEMS Microbiol Lett."},{"key":"B134","doi-asserted-by":"publisher","first-page":"e01379","DOI":"10.1128\/mBio.01379-14","article-title":"Engineered endolysin-based \u201cArtilysins\u201d to combat multidrug-resistant Gram-negative pathogens","volume":"5","author":"Briers","year":"2014","journal-title":"mBio"},{"key":"B135","doi-asserted-by":"publisher","first-page":"22","DOI":"10.24075\/brsmu.2018.010","article-title":"Physical and chemical properties of recombinant KPP10 phage lysins and their antimicrobial activity against Pseudomonas aeruginosa","volume":"7","author":"Antonova","year":"2018","journal-title":"Bull RSMU"},{"key":"B136","doi-asserted-by":"publisher","first-page":"35382","DOI":"10.1038\/srep35382","article-title":"'Artilysation' of endolysin lSa2lys strongly improves its enzymatic and antibacterial activity against streptococci","volume":"6","author":"Rodr\u00edguez-Rubio","year":"2016","journal-title":"Sci Rep"},{"key":"B137","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.femsre.2004.05.002","article-title":"Recent trends on the molecular biology of pneumococcal capsules, lytic enzymes, and bacteriophage","volume":"28","author":"L\u00f3pez","year":"2004","journal-title":"FEMS Microbiol Rev"},{"key":"B138","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/0378-1119(90)90116-9","article-title":"Modular organization of the lytic enzymes of Streptococcus pneumoniae and its bacteriophages","volume":"86","author":"Garc\u00eda","year":"1990","journal-title":"Gene"},{"key":"B139","doi-asserted-by":"publisher","first-page":"33184","DOI":"10.1074\/jbc.M110.154559","article-title":"Cpl-7, a lysozyme encoded by a pneumococcal bacteriophage with a novel cell wall-binding motif","volume":"285","author":"Bustamante","year":"2010","journal-title":"J Biol Chem"},{"key":"B140","doi-asserted-by":"publisher","first-page":"16494","DOI":"10.1038\/s41598-017-16392-4","article-title":"Deciphering how Cpl-7 cell wall-binding repeats recognize the bacterial peptidoglycan","volume":"7","author":"Bustamante","year":"2017","journal-title":"Sci Rep"},{"key":"B141","author":"World","year":"2014","journal-title":"Antimicrobial Resistance: Global Report on Surveillance"},{"key":"B142","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/82","article-title":"Envelope structures of Gram-positive bacteria","volume":"404","author":"Rajagopal","year":"2017","journal-title":"Curr Top Microbiol Immunol"},{"key":"B143","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1128\/AEM.01616-06","article-title":"Lytic activity of recombinant bacteriophage \u03c611 and \u03c612 endolysins on whole cells and biofilms of Staphylococcus aureus","volume":"73","author":"Sass","year":"2007","journal-title":"Appl Environ Microbiol"},{"key":"B144","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1099\/mic.0.27063-0","article-title":"The bifunctional peptidoglycan lysin of Streptococcus agalactiae bacteriophage B30","volume":"150","author":"Pritchard","year":"2004","journal-title":"Microbiology"},{"key":"B145","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.1128\/JB.188.7.2463-2472.2006","article-title":"Cross-linked peptidoglycan mediates lysostaphin binding to the cell wall envelope of Staphylococcus aureus","volume":"188","author":"Gr\u00fcndling","year":"2006","journal-title":"J Bacteriol."},{"key":"B146","doi-asserted-by":"publisher","first-page":"4416","DOI":"10.1128\/AAC.00217-11","article-title":"In vitro activity against Staphylococcus aureus of a novel antimicrobial agent, PRF-119, a recombinant chimeric bacteriophage endolysin","volume":"55","author":"Idelevich","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"B147","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1128\/AAC.02859-15","article-title":"The recombinant bacteriophage endolysin HY-133 exhibits in vitro activity against different African clonal lineages of the Staphylococcus aureus complex, including Staphylococcus schweitzeri","volume":"60","author":"Idelevich","year":"2016","journal-title":"Antimicrob Agents Chemother."},{"key":"B148","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1128\/AEM.07050-11","article-title":"Chimeric phage lysins act synergistically with lysostaphin to kill mastitis-causing Staphylococcus aureus in murine mammary glands","volume":"78","author":"Schmelcher","year":"2012","journal-title":"Appl Environ Microbiol"},{"key":"B149","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/1574-6968.12104","article-title":"Chimeric Ply187 endolysin kills Staphylococcus aureus more effectively than the parental enzyme","volume":"342","author":"Mao","year":"2013","journal-title":"FEMS Microbiol Lett"},{"key":"B150","doi-asserted-by":"publisher","first-page":"25063","DOI":"10.1038\/srep25063","article-title":"Triple-acting lytic enzyme treatment of drug-resistant and intracellular Staphylococcus aureus","volume":"6","author":"Becker","year":"2016","journal-title":"Sci Rep."},{"key":"B151","doi-asserted-by":"publisher","first-page":"e00380","DOI":"10.1128\/AEM.00380-18","article-title":"A phage lysin fused to a cell-penetrating peptide kills intracellular methicillin-resistant Staphylococcus aureus in keratinocytes and has potential as a treatment for skin infections in mice","volume":"84","author":"Wang","year":"2018","journal-title":"Appl Environ Microbiol."},{"key":"B152","doi-asserted-by":"publisher","first-page":"3739","DOI":"10.1002\/1873-3468.12254","article-title":"Streptococcus pyogenes adhesion and colonization","volume":"590","author":"Brouwer","year":"2016","journal-title":"FEBS Lett."},{"key":"B153","doi-asserted-by":"publisher","first-page":"e223","DOI":"10.1016\/S1473-3099(17)30232-3","article-title":"Group B streptococcus and respiratory syncytial virus immunisation during pregnancy: a landscape analysis","volume":"17","author":"Heath","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"B154","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1002\/chem.201702973","article-title":"Chemistry of peptidoglycan in Mycobacterium tuberculosis life cycle: an off-the-wall balance of synthesis and degradation","volume":"24","author":"Squeglia","year":"2018","journal-title":"Chemistry"},{"key":"B155","doi-asserted-by":"publisher","first-page":"e34052","DOI":"10.1371\/journal.pone.0034052","article-title":"Mycobacteriophage endolysins: diverse and modular enzymes with multiple catalytic activities","volume":"7","author":"Payne","year":"2012","journal-title":"PLoS ONE"},{"key":"B156","doi-asserted-by":"publisher","first-page":"428","DOI":"10.3390\/v10080428","article-title":"Mycobacteriophage lysis enzymes: targeting the mycobacterial cell envelope","volume":"10","author":"Catal\u00e3o","year":"2018","journal-title":"Viruses"},{"key":"B157","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nrmicro.2017.42","article-title":"Persistent bacterial infections and persister cells","volume":"15","author":"Fisher","year":"2017","journal-title":"Nat Rev Microbiol"},{"key":"B158","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0014-5793(99)00405-6","article-title":"The non-enzymatic microbicidal activity of lysozymes","volume":"449","author":"D\u00fcring","year":"1999","journal-title":"FEBS Lett"},{"key":"B159","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.peptides.2005.07.001","article-title":"Identification of antimicrobial peptide regions derived from genomic sequences of phage lysins","volume":"27","author":"Rotem","year":"2006","journal-title":"Peptides"},{"key":"B160","doi-asserted-by":"publisher","first-page":"449","DOI":"10.3389\/fmicb.2015.00449","article-title":"Structural constraints and dynamics of bacterial cell wall architecture","volume":"6","author":"de","year":"2015","journal-title":"Front Microbiol."},{"key":"B161","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41426-018-0030-4","article-title":"Acinetobacter: an emerging pathogen with a versatile secretome","volume":"7","author":"Elhosseiny","year":"2018","journal-title":"Emerg Microb Infect"},{"key":"B162","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s11908-018-0617-x","article-title":"The epidemiology, evolution, and treatment of KPC-producing organisms","volume":"20","author":"Porreca","year":"2018","journal-title":"Curr Infect Dis Rep."},{"key":"B163","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.pep.2005.03.026","article-title":"Cloning and expression of Klebsiella phage K11 lysozyme gene","volume":"42","author":"Junn","year":"2005","journal-title":"Protein Expr Purif."},{"key":"B164","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1007\/s10096-016-2703-z","article-title":"Nosocomial pneumonia in 27 ICUs in Europe: perspectives from the EU-VAP\/CAP study","volume":"36","author":"Koulenti","year":"2017","journal-title":"Eur J Clin Microbiol Infect Dis."},{"key":"B165","doi-asserted-by":"publisher","first-page":"9857","DOI":"10.1073\/pnas.1203472109","article-title":"Structural engineering of a phage lysin that targets gram-negative pathogens","volume":"109","author":"Lukacik","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"B166","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.3389\/fmicb.2018.01033","article-title":"Thousands of novel endolysins discovered in uncultured phage genomes","volume":"9","author":"Fern\u00e1ndez-Ruiz","year":"2018","journal-title":"Front Microbiol"},{"key":"B167","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/smll.200801042","article-title":"Multifunctional Fe3O4@Au nanoeggs as photothermal agents for selective killing of nosocomial and antibiotic-resistant bacteria","volume":"5","author":"Huang","year":"2009","journal-title":"Small"},{"key":"B168","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1021\/nn700183g","article-title":"Vancomycin-modified nanoparticles for efficient targeting and preconcentration of Gram-positive and Gram-negative bacteria","volume":"2","author":"Kell","year":"2008","journal-title":"ACS Nano"},{"key":"B169","doi-asserted-by":"publisher","first-page":"6005","DOI":"10.1021\/am405332a","article-title":"Ligand engineering of polymer nanocomposites: from the simple to the complex","volume":"6","author":"Li","year":"2014","journal-title":"ACS Appl Mater Interfaces"},{"key":"B170","doi-asserted-by":"publisher","first-page":"4591","DOI":"10.1039\/c2cc17766h","article-title":"Photosensitizer and vancomycin-conjugated novel multifunctional magnetic particles as photoinactivation agents for selective killing of pathogenic bacteria","volume":"48","author":"Choi","year":"2012","journal-title":"Chem Commun."},{"key":"B171","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1007\/s00253-018-8811-1","article-title":"Applications of bacteriophages versus phage enzymes to combat and cure bacterial infections: an ambitious and also a realistic application?","volume":"102","author":"Maciejewska","year":"2018","journal-title":"Appl Microbiol Biotechnol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.02252\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T05:19:42Z","timestamp":1539667182000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.02252\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,16]]},"references-count":171,"alternative-id":["10.3389\/fimmu.2018.02252"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.02252","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,16]]},"article-number":"2252"}}